Skip to main navigation

Skip to Content

Overview
Stock Information
News & Events
Financials
- SEC Filings
- Analyst Coverage
Governance
- Governance Highlights
- Committee Composition
Investor Resources

News Releases

2018 Investor Presentation

Year

May 11, 2021

Harmony Biosciences Reports First Quarter 2021 Results and Business Updates

Apr 27, 2021

Harmony Biosciences Announces Date of First Quarter 2021 Financial Results

Apr 27, 2021

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

Apr 12, 2021

Harmony Biosciences To Present WAKIX® (Pitolisant) Data At The 2021 AAN Annual Meeting

Apr 07, 2021

Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders

Mar 25, 2021

Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates

Mar 19, 2021

Harmony Biosciences Hosts Summit Which Sheds Light on Impact of Sleep Disruption in Rare Diseases

Mar 17, 2021

Harmony Biosciences Highlights Publication of WAKIX® (pitolisant) Efficacy Data in Sleep Medicine

Mar 15, 2021

Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer

Mar 04, 2021

Harmony Biosciences Announces Date Of Fourth Quarter And Full Year 2020 Financial Results

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 11

Site - Shareholder Tools

Copyright © 2021 Harmony Biosciences All rights reserved.

Facebook
Twitter
LinkedIn
Google+